Margaret McLoughlin insider trades

Open-market stock purchases and sales by Margaret McLoughlin, Unknown at Quince Therapeutics, Inc, from SEC Form 4 filings since May 8, 2019.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -19%.

Recent trades

DateStockTradeValue
Jan 2, 2026QNCX Quince Therapeutics, IncBought (not open market)—

Companies traded

  • QNCX Quince Therapeutics, Inc: 1 buy, last Jan 2, 2026
  • CRTX Cortexyme, Inc: 1 buy, 9 sales, last Jun 8, 2022

Get free alerts when Margaret McLoughlin files a new trade →